Metabolites
Displaying compounds 14051 - 14075 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB00148 | Chorismate 55508-12-8 | (3R,4R)-3-[(1-carboxyeth-1-en-1-yl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylic acid | C10H10O6 226.1828 | |
| YMDB00227 | Choline 62-49-7 | (2-hydroxyethyl)trimethylazanium | C5H14NO 104.1708 | |
| YMDB00313 | Cholesterol 57-88-5 | (1S,2R,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-ol | C27H46O 386.6535 | |
| YMDB15975 | Chlorobenzene | chlorobenzene | C6H5Cl 112.557 | |
| YMDB01517 | Chloride 16887-00-6 | chloride | Cl 35.453 | |
| YMDB16156 | Chitin | C28H49N3O16 683.6992 | ||
| YMDB00785 | cerotic acid 57-10-3 | hexacosanoic acid | C26H52O2 396.6899 | |
| YMDB16182 | Ceramide (d18:1/18:0) | N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]octadecanamide | C36H71NO3 565.9538 | |
| YMDB01110 | Cer 20:0;3/26:0;1 | (9R)-9-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyicosan-2-yl]hexacosanamide | C46H93NO5 740.2343 | |
| YMDB01109 | Cer 18:0;3/26:0;1 | (9R)-9-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]hexacosanamide | C44H89NO5 712.1812 | |
| YMDB01108 | Cer 18:0;3/26:0;0 | N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]hexacosanamide | C44H89NO4 696.1818 | |
| YMDB01107 | Cer 18:0;3/24:0;1 | (9R)-9-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]tetracosanamide | C42H85NO5 684.128 | |
| YMDB01106 | Cer 18:0;3/22:0;1 | (9R)-9-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]docosanamide | C40H81NO5 656.0748 | |
| YMDB01105 | Cer 18:0;3/22:0;0 | N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]docosanamide | C40H81NO4 640.0754 | |
| YMDB01104 | Cer 18:0;3/20:0;1 | (9R)-9-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]icosanamide | C38H77NO5 628.0217 | |
| YMDB01103 | Cer 18:0;3/18:0;1 | (9R)-9-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]octadecanamide | C36H73NO5 599.9685 | |
| YMDB01102 | Cer 18:0;3/16:0;0 | N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]hexadecanamide | C34H69NO4 555.916 | |
| YMDB00869 | Cellobiose 528-50-7 | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol | C12H22O11 342.2965 | |
| YMDB16199 | CE(18:0) | (2R,5S,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl octadecanoate | C45H80O2 653.1155 | |
| YMDB16121 | CE(16:0) | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl hexadecanoate | C43H76O2 625.0623 | |
| YMDB16187 | CE(14:0) | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl tetradecanoate | C41H72O2 597.0092 | |
| YMDB16149 | CE(12:0) | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl dodecanoate | C39H68O2 568.956 | |
| YMDB16161 | CE(10:0) | 2,15-dimethyl-14-(6-methylheptan-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl decanoate | C37H64O2 540.9029 | |
| YMDB00867 | CDP-ribitol 3506-17-0 | {[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[hydroxy({[(2R,3S,4S)-2,3,4,5-tetrahydroxypentyl]oxy})phosphoryl]oxy})phosphinic acid | C14H25N3O15P2 537.3069 | |
| YMDB00389 | CDP-Ethanolamine 3036-18-8 | (2-aminoethoxy)[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphinic acid | C11H20N4O11P2 446.2442 |